Skip to Main Content

INFORMATION FOR

Abu-Sayeef Mirza

MD, MPH, FACP
Clinical Fellow

Contact Information

Abu-Sayeef Mirza, MD, MPH, FACP

Coauthors

Selected Publications

  • Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene VicleucelMirza A, Pine A, Rasheed Y, Hamouche R, Leveille E, Goshua G, Gu S, Liu Y, VanOudenhove J, Bar N, Neparidze N, Foss F, Gowda L, Isufi I, Halene S, Lee A, Seropian S. Proteomic Profiles of Cytokine Release Syndromes Following Lisocabtagene Maraleucel and Idecabtagene Vicleucel Blood 2022, 140: 10410-10412. DOI: 10.1182/blood-2022-168374.
  • Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR)Mirza A, Hosing C, Foss F, Kim S, Moskop A, Oloyede T, Ahmed S, Hematti P, Turtle C, Pasquini M, Gowda L. Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR) Blood 2022, 140: 4633-4635. DOI: 10.1182/blood-2022-163750.
  • CD25 As Feedback Regulator of Oncogenic TCR Signaling in T-Cell LymphomaSun R, Lee J, Wartewig T, Robinson M, Bigogno A, Fonseca Arce D, Mirza A, Takeda A, Klemm L, Vykunta V, Shy B, Marson A, Müschen M. CD25 As Feedback Regulator of Oncogenic TCR Signaling in T-Cell Lymphoma Blood 2022, 140: 5975-5976. DOI: 10.1182/blood-2022-170076.
  • 168 Impact of Post-Remission Consolidation Therapy on Outcomes of Haploidentical Hematopoietic Cell Transplantation for Acute Myelogenous LeukemiaMirza A, Byrne M, Huntington S, Shallis R, Zeidan A, Foss F, Isufi I, Podoltsev N, Engelhardt B, Kassim A, Savani B, Dholaria B, Jayani R, Perrault S, Schiffer M, Seropian S, Gowda L. 168 Impact of Post-Remission Consolidation Therapy on Outcomes of Haploidentical Hematopoietic Cell Transplantation for Acute Myelogenous Leukemia Transplantation And Cellular Therapy 2022, 28: s139-s140. DOI: 10.1016/s2666-6367(22)00329-3.
  • 167 Measurable Residual Disease Outcompetes Cytogenetics in Predicting Leukemia Free Survival Following Allogeneic Stem Cell Transplantation Outcomes in Adults with Acute Lymphoblastic LeukemiaFaramand R, Cao B, Mirza A, Kim J, Bunting S, Castaneda O, Davila M, Elmariah H, Freeman C, Hansen D, Jain M, Khimani F, Locke F, Liu H, Pidala J, Ochoa L, Mishra A, Nieder M, Nishihori T, Alsina M, Perez L, Shah B, Anasetti C, Bejanyan N, Lazaryan A. 167 Measurable Residual Disease Outcompetes Cytogenetics in Predicting Leukemia Free Survival Following Allogeneic Stem Cell Transplantation Outcomes in Adults with Acute Lymphoblastic Leukemia Transplantation And Cellular Therapy 2022, 28: s138-s139. DOI: 10.1016/s2666-6367(22)00328-1.
  • Real-World Outcomes of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Large B-Cell Lymphoma (LBCL): Impact of Age and Specific Organ DysfunctionLocke F, Jacobson C, Ma L, Dong H, Hu Z, Siddiqi T, Ahmed S, Ghobadi A, Miklos D, Lin Y, Perales M, Lunning M, Herr M, Hill B, Ganguly S, Mirza A, Nikiforow S, Xu H, Pasquini M. Real-World Outcomes of Axicabtagene Ciloleucel (Axi-cel) for the Treatment of Large B-Cell Lymphoma (LBCL): Impact of Age and Specific Organ Dysfunction Blood 2021, 138: 530-530. DOI: 10.1182/blood-2021-149679.
  • Abstract PO-248: Breast cancer risk factors, prevalence, and screening rates in uninsured women seen at free clinicsMacDonald M, Swanson J, Shah S, Vivar J, Song E, Ahsan T, Mhaskar R, Mirza A. Abstract PO-248: Breast cancer risk factors, prevalence, and screening rates in uninsured women seen at free clinics Cancer Epidemiology Biomarkers & Prevention 2020, 29: po-248-po-248. DOI: 10.1158/1538-7755.disp20-po-248.
  • Abstract A019: Substance use in uninsured cancer survivors from free clinicsMacDonald M, Shah S, Swanson J, Song E, Mhaskar R, Pabbathi S, Mirza A. Abstract A019: Substance use in uninsured cancer survivors from free clinics Cancer Epidemiology Biomarkers & Prevention 2020, 29: a019-a019. DOI: 10.1158/1538-7755.disp19-a019.
  • The complex comorbidities of uninsured cancer patients.Shah S, MacDonald M, Lu Y, Pabbathi S, Mirza A. The complex comorbidities of uninsured cancer patients. Journal Of Clinical Oncology 2020, 38: e19054-e19054. DOI: 10.1200/jco.2020.38.15_suppl.e19054.
  • Hypofibrinogenemia in Patients Receiving CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Large B Cell Lymphoma: A Single Institution ExperienceHashmi H, Mirza A, Darwin A, Logothetis C, Garcia F, Kommalapati A, Bachmeier C, Benson K, Chavez J, Shah B, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila M, Nishihori T, Jain M, Locke F. Hypofibrinogenemia in Patients Receiving CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Large B Cell Lymphoma: A Single Institution Experience Transplantation And Cellular Therapy 2020, 26: s257-s258. DOI: 10.1016/j.bbmt.2019.12.451.
  • Incidence and Management of Venous Thrombo-Embolism (VTE) Associated with CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Single Institution ExperienceHashmi H, Mirza A, Darwin A, Logothetis C, Garcia F, Kommalapati A, Bachmeier C, Chavez J, Shah B, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila M, Jain M, Locke F, Nishihori T. Incidence and Management of Venous Thrombo-Embolism (VTE) Associated with CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy: A Single Institution Experience Transplantation And Cellular Therapy 2020, 26: s265. DOI: 10.1016/j.bbmt.2019.12.430.
  • Incidence and Management of Effusions during CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Receptor Therapy in B-Cell Lymphoma: A Single Institution ExperienceMirza A, Hashmi H, Darwin A, Garcia F, Kommalapati A, Logothetis C, Bachmeier C, Chavez J, Shah B, Pinilla-Ibarz J, Khimani F, Lazaryan A, Liu H, Davila M, Nishihori T, Locke F, Jain M. Incidence and Management of Effusions during CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Receptor Therapy in B-Cell Lymphoma: A Single Institution Experience Transplantation And Cellular Therapy 2020, 26: s265-s266. DOI: 10.1016/j.bbmt.2019.12.431.
  • Colorectal cancer prevalence and risk factors among the uninsured of Tampa Bay: A free clinic study.Song E, Patel A, Swanson J, Aponte A, MacDonald M, Segarra D, Shah N, Ayoubi N, Mirza A. Colorectal cancer prevalence and risk factors among the uninsured of Tampa Bay: A free clinic study. Journal Of Clinical Oncology 2020, 38: 61-61. DOI: 10.1200/jco.2020.38.4_suppl.61.
  • Demographic Characteristics and Management of Uninsured Patients with a History of MelanomaUniversity of South Florida M, Ayoubi N, Mirza A, Department of Internal Medicine, Ayoubi M, University of South Florida C, Swanson J, University of South Florida C. Demographic Characteristics and Management of Uninsured Patients with a History of Melanoma Dermatology - Open Journal 2019, 4: 15-19. DOI: 10.17140/drmtoj-4-136.
  • 189. A Case Series of Elizabethkingia meningosepticum Bacteremia in the Cancer PopulationHyun Lee D, Mehra I, Chandrasekhar S, Mirza A, Shenoy R, Topham A, Nanjappa S, Greene J. 189. A Case Series of Elizabethkingia meningosepticum Bacteremia in the Cancer Population Open Forum Infectious Diseases 2019, 6: s114-s115. PMCID: PMC6810268, DOI: 10.1093/ofid/ofz360.264.
  • 464 The Burden of Chronic Gastrointestinal Diseases Among the Uninsured: A Free Clinic StudySong E, Aponte A, Swanson J, Patel A, Shah N, Segarra D, MacDonald M, Mirza A. 464 The Burden of Chronic Gastrointestinal Diseases Among the Uninsured: A Free Clinic Study The American Journal Of Gastroenterology 2019, 114: s271-s271. DOI: 10.14309/01.ajg.0000591388.31133.09.
  • Thrombosis in Acute Myeloid Leukemia: A Moffitt Cancer Center ExperienceMirza A, Yun S, Ali N, Shin H, O’Neil J, Elharake M, Schwartz D, Robinson K, Nowell E, Engle G, Badat I, Brimer T, Kuc A, Sequeira A, Mirza S, Sikaria D, Vera J, Hackney N, Abusrur S, Jesurajan J, Kuang J, Patel S, Khalil S, Bhaskar S, Beard A, Abuelenen T, Ratnasamy K, Visweshwar N, Komrokji R, Jaglal M. Thrombosis in Acute Myeloid Leukemia: A Moffitt Cancer Center Experience Clinical Lymphoma Myeloma & Leukemia 2019, 19: s223. DOI: 10.1016/j.clml.2019.07.099.
  • Socioeconomic disparities among uninsured cancer patients: A free clinic study.MacDonald M, Lu Y, Song E, Ayoubi N, Robinson K, Todd A, Mirza A. Socioeconomic disparities among uninsured cancer patients: A free clinic study. Journal Of Clinical Oncology 2019, 37: e18110-e18110. DOI: 10.1200/jco.2019.37.15_suppl.e18110.
  • BPI19-018: Cancer Screening Rates and Adherence of Uninsured Cancer Patients in Free ClinicsRobinson K, Todd A, Mirza A, Macdonald M, Ayoubi N, Mhaskar R, Roetzheim R, Woodard L, Pabbathi S. BPI19-018: Cancer Screening Rates and Adherence of Uninsured Cancer Patients in Free Clinics Journal Of The National Comprehensive Cancer Network 2019, 17: bpi19-018. DOI: 10.6004/jnccn.2018.7242.
  • Outcomes of Primary Effusion Lymphoma: The Role of Autologous Hematopoietic Cell TransplantationMirza A, Dholaria B, Hussaini M, Mushtaq S, Ravindran A, Kumar A, Sokol L. Outcomes of Primary Effusion Lymphoma: The Role of Autologous Hematopoietic Cell Transplantation Clinical Lymphoma Myeloma & Leukemia 2018, 18: s291. DOI: 10.1016/j.clml.2018.07.233.
  • Morbidities and socioeconomic factors of uninsured patients with cancer in free clinics.Robinson K, Mirza A, Lu Y, Ayoubi N, Ewing A, Mhaskar R, Roetzheim R, Pabbathi S. Morbidities and socioeconomic factors of uninsured patients with cancer in free clinics. Journal Of Clinical Oncology 2018, 36: e18681-e18681. DOI: 10.1200/jco.2018.36.15_suppl.e18681.
  • A single-institution study of renal outcomes in patients receiving checkpoint inhibitors.Mushtaq S, Kerr D, Mirza A, Shah B, Bassil C. A single-institution study of renal outcomes in patients receiving checkpoint inhibitors. Journal Of Clinical Oncology 2018, 36: e15079-e15079. DOI: 10.1200/jco.2018.36.15_suppl.e15079.
  • 384 Assessing dermatologic care of uninsured patients managed at free clinicsAyoubi N, Mirza A. 384 Assessing dermatologic care of uninsured patients managed at free clinics Journal Of Investigative Dermatology 2018, 138: s65. DOI: 10.1016/j.jid.2018.03.390.
  • A single-center study of cancer and chemotherapy-induced kidney disease.Mirza A, Mushtaq S, Reddy R, Mousa M, Bohra C, Kongpakpaisarn K, Verma S, Mhaskar R, Jaglal M, Bassil C. A single-center study of cancer and chemotherapy-induced kidney disease. Journal Of Clinical Oncology 2017, 35: e13062-e13062. DOI: 10.1200/jco.2017.35.15_suppl.e13062.
  • Knowledge, attitudes and practices among patients with coronary artery disease in Dhaka, BangladeshMirza A, Aslam S, Perrin K, Curtis T, Stenback J, Gipson J, Alrabaa S. Knowledge, attitudes and practices among patients with coronary artery disease in Dhaka, Bangladesh International Journal Of Community Medicine And Public Health 2016, 3: 2740-2748. DOI: 10.18203/2394-6040.ijcmph20163355.